Advertisement

 

 

Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China.

Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China.
Author Information (click to view)

Zuo Z, Liang S, Sun X, Bussell S, Yan J, Kan W, Leng X, Liao L, Ruan Y, Shao Y, Xing H,


Zuo Z, Liang S, Sun X, Bussell S, Yan J, Kan W, Leng X, Liao L, Ruan Y, Shao Y, Xing H, (click to view)

Zuo Z, Liang S, Sun X, Bussell S, Yan J, Kan W, Leng X, Liao L, Ruan Y, Shao Y, Xing H,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

PloS one 2016 12 2011(12) e0166661 doi 10.1371/journal.pone.0166661

Abstract
BACKGROUND
China’s National Free Antiretroviral Treatment Program (NFATP) has substantially increased the survival rate since 2002. However, the emergence of HIV drug resistance (HIVDR) limits the durability and effectiveness of antiretroviral treatment (ART) in at risk patients.

METHOD
A cross-sectional survey was conducted among patients having received a median of 13.9 months of ART in eight provinces in China. Demographic and clinical information was collected, and venous blood was sampled for CD4 cell counts, measurement of the HIV viral load (VL), and HIV drug resistance (HIVDR) genotyping. Possible risk factors for HIVDR were analyzed by the logistic regression model.

RESULTS
The study included 765 patients. Among them, 65 patients (8.5%) had virological failure (VLF) defined as ≥1,000 copies/ml. Among the individuals with VLF, 64 were successful genotyped, and of these, 33 had one or more HIVDR mutations. The prevalence of HIVDR mutations among patients receiving first-line ART was 4.3% (33/765). All of the patients with HIVDR mutations were resistant to non-nucleoside transcriptase inhibitors, 81.8% were resistant to nucleoside reverse transcriptase inhibitors, and only 3% had mutations that caused resistance to protease inhibitors. Having lower ratios of drug intake in the past month and dwelling in two southwestern provinces were factors independently associated with the emergence of HIVDR.

CONCLUSION
Most patients receiving first-line ART treatment achieved sound virological and immunological outcomes. However, poor adherence is still a key problem, which has led to the high rate of HIVDR. It was notable that the proportion of drug resistance widely varied among the provinces. More studies are needed to focus on adherence.

Submit a Comment

Your email address will not be published. Required fields are marked *

16 + eighteen =

[ HIDE/SHOW ]